Loading clinical trials...
Loading clinical trials...
A Double-Blind, Randomised, Placebo-Controlled Multi-Centre Field Study to Assess the Efficacy and Safety of Cat-PAD Peptide Immunotherapy in Cat Allergic Subjects
Conditions
Interventions
Cat-PAD
Placebo
Locations
118
United States
Rolling Hills Estates, California, United States
Colorado Springs, Colorado, United States
Denver, Colorado, United States
Wheat Ridge, Colorado, United States
Eagle, Idaho, United States
Meridian, Idaho, United States
Start Date
October 1, 2012
Primary Completion Date
June 1, 2016
Last Updated
June 15, 2018
NCT04435990
NCT06778213
NCT07427576
NCT06922448
NCT04502966
NCT05560698
Lead Sponsor
Circassia Limited
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions